Targon PH+ Follow-Up

Aesculap AG50 enrolled

Overview

With this study results of the Targon® PH+ nail, developed for the treatment of humeral head fractures, will be investigated clinically, radiological evaluation is optional. The primary objective of this study is to examine the effect of a plating treatment on the speed of recovery of functional capacity in adult patients. Secondary aims are to examine the level of pain, patient satisfaction, shoulder function, quality of life, radiological evaluation and complications. Targon PH+ is CE certified. The study is a non-interventional cohort study sponsored by Aesculap

Study Type

OBSERVATIONAL

Enrollment

Conditions

Shoulder Fractures

Eligibility

Sex: ALLMin age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: - patients with a three- or four-fragment-fracture of the proximal humerus, with dislocation on X-ray * older than 60 years of age * written and signed patient consent Exclusion Criteria: - Fractures more than 14 days old * multiple comorbidity * multitrauma (Injury Severity Score \> 15) * prev. surgery on the injured shoulder * severely deranged function caused by a previous disease head-split proximal humerus fracture * combined humerus head and shaft fractures * pseudarthroses * crushed head cap of the humerus head (AO 11 C3 fractures) * isolated avulsion fracture of a tuberosity * unwillingness or inability to follow protocol instructions and study requirements (follow-up visits) * no signed informed consent * treatment not in line with Instructions for Use (IfU)

Locations (1)

Klinikum Nürnberg Süd

Nuremberg, Bavaria, Germany

Outcomes

Primary Outcomes

Functional Capacity

The DASH score (Disabilities of the Arm, Shoulder, and Hand) will be used to determine the recovery of functional capacity. It provides a summary of the responses on a scale of 0 (no disability) to 100 (severe disability)

Time frame: 24 months

Secondary Outcomes

Level of pain

10-point Visual Analogue Scale (VAS) from no pain (0) to most extreme pain imaginable (10)

Time frame: 3, 12 and 24 months

Patient satisfaction

4 point scale: very satisfied, satisfied, unsatisfied, very unsatisfied

Time frame: 24 months

Shoulder Function

Shoulder function outcome is measured with the Constant-Murley score, this score system combines shoulder function tests (65 points) with a subjective evaluation of the patients (35 points) including activities of daily living, level of work

Time frame: 12 months, 24 months

Radiological outcome (only if it could be raised in clinical standard)

The X-rays are examined regarding adverse events as screw perforation, screw breakage, cut-out, re-dislocation of the fracture

Time frame: 24 months

Adverse Events

Rate of Adverse Events, for example secondary interventions (revisions) that occur within the follow-up period

Time frame: 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.